EMR - AspenTech announces HSR and Austrian antitrust approval

Aspen Technology (AZPN +2.6%) has announced, in connection with its proposed transaction with Emerson (EMR -0.6%), the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and antitrust clearance from the Austrian Federal Competition Authority. Expiration of the waiting period under the HSR Act and Austrian antitrust approval satisfy two conditions to the closing of the pending transaction, which was announced on October 11, 2021. The closing of the transaction is expected to occur in the second calendar quarter of 2022.

For further details see:

AspenTech announces HSR and Austrian antitrust approval